Revvity | 营业利润

股票价格
98.31
每天变化
-0.70 -0.71%
每月一次
-11.54%
每年
-12.34%
Q1 预测
95.30


金融业
股票价格
USD
资产
USD 12.17B
现金及等价物
USD 919.86M
销售成本
USD 350.4M
流动资产
USD 2.24B
流动负债
USD 1.33B
债务
USD 3.37B
股息收益率
0.29
EBIT
USD 145.83M
EBITDA
USD 248.91M
员工
11K
EPS每股收益
USD 1.7
股本和储备
USD 7.38B
销售毛利
USD 421.66M
债务利息支出
USD 23.51M
利息收入
USD 0.4
贷款资金
USD 2.63B
市值
USD 12.14B
净收入
USD 98.36M
营业费用
USD 626.22M
营业利润
USD 145.83M
普通股股本
USD 113.38M
PE价格收益
USD 49.87
税前利润
USD 55.68M
销售收入
USD 772.06M
销售和管理费用
USD 251.73M
股票
USD 379.5M
贸易债权人
USD 185.46M
应收帐款人
USD 744.67M


营业利润 更改 日
Agilent USD 353M 90M 2025-12
Align Technology USD 224.71M 40.06M 2025-12
Bio Techne USD 54.46M 6.8M 2025-12
Bio-Rad Laboratories USD 63.9M 13.2M 2025-09
Bruker USD 76.3M 7.6M 2025-12
Celltrion KRW 301.04B 58.57B 2025-09
Charles River Laboratories USD 75.82M 57.98M 2025-12
Cspc Pharmaceutical CNY 1.22B 60.54M 2025-09
Danaher USD 1.5B 348M 2025-12
Dentsply International USD 538M 26M 2025-12
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -40.29M 5.36M 2025-09
Divis Laboratories Ltd INR 7.72B 30M 2025-12
Edwards Lifesciences USD 370.3M 54.8M 2025-12
Exact Sciences USD -25M 22.85M 2025-09
Hologic USD 237M 16M 2025-12
Illumina USD 256M 6M 2025-12
Intuitive Surgical USD 865.3M 97.5M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Laboratory Of America USD 382M 15.3M 2025-12
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -480K 662K 2025-06
Mesa Laboratories USD 5.78M 2.27M 2024-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -23.3M 10.8M 2025-09
Neuren Pharmaceuticals AUD 5.45M 171.24M 2025-06
OraSure Technologies USD -6M 3.26M 2024-09
Organigram Holdings CAD -28.05M 7.76M 2025-09
Ovoca Bio EUR -5.65M 3.45M 2022-06
Pacific Biosciences Of California USD -64.08M 111.77M 2024-09
Pharma Mar EUR -3.96M 28.06M 2025-09
Qiagen NV USD 121.88M 15.41M 2025-12
Quest Diagnostics USD 386M 0 2025-12
Quidel USD -37.3M 667.5M 2025-12
Repligen USD 19.97M 7.29M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Sartorius EUR 150.1M 11.7M 2025-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Tilray USD -20.01M 9.34M 2025-09
Waters USD 270.52M 78.4M 2025-12
Zz Pientze Pharmaceu CNY 501.33M 52.54M 2025-09


Revvity 营业利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.